On January 5, 2022, Mr. Kenneth Galbraith, a member of the board of directors of MacroGenics, Inc. notified the Board of his decision to resign from the Board, effective immediately. Mr. Galbraith was the Chair of the Audit Committee. Mr. Galbraith will be leaving his position on the Board to pursue a new opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.12 USD | -3.96% | -17.43% | -57.17% |
Jun. 13 | Transcript : MacroGenics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:00 AM | |
May. 10 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.17% | 258M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- MGNX Stock
- News MacroGenics, Inc.
- MacroGenics, Inc. Announces Resignation of Kenneth Galbraith as A Member of the Board of Directors